The comparison of a NanoCelle cannabis formulation (NanaBis) and a cannabis oil formulation derived from the same raw cannabis oil material administered in equal concentration to the oral mucosa in healthy volunteers: a pharmacokinetic, open-label, randomised exploratory study
Latest Information Update: 14 Feb 2020
At a glance
- Drugs Nabiximols (Primary) ; Nabiximols (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Medlab
Most Recent Events
- 02 Dec 2020 Planned initiation date changed from 3 Feb 2020 to 15 Jun 2020.
- 30 Oct 2019 New trial record